2427 — Guanze Medical Information Industry (Holding) Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$570.00m
- HK$550.73m
- CNY155.74m
- 76
- 26
- 64
- 59
Annual cashflow statement for Guanze Medical Information Industry (Holding) Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 39 | 33.1 | 30 | 38.6 | 26.3 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 1.21 | 2.6 | 1.2 | -3.98 | 6.54 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -15.3 | -37 | -27.1 | -31.8 | -18.6 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 28.2 | 3.09 | 9.31 | 8.85 | 21.5 |
| Capital Expenditures | -14.4 | -7.86 | -9.33 | -7.3 | -29.1 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.051 | 0 | 0 | 0 | — |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -14.3 | -7.86 | -9.33 | -7.3 | -29.1 |
| Financing Cash Flow Items | 31.2 | 1.49 | -11.9 | -22 | -10.5 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -14.8 | 19.5 | 9.15 | 37.4 | -32.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.973 | 14.7 | 9.13 | 39 | -40.1 |